- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02463552
Naproxen on Tooth Sensitivity Caused by In-office Bleaching
October 24, 2016 updated by: André Luis Faria e Silva, Universidade Federal de Sergipe
Rior Use of Naproxen on Tooth Sensitivity Reduction After In-office Bleaching: Randomized Clinical Trial
This study aims to evaluate the effects of prior use of non-steroidal anti-inflammatory Naproxen on risk and level of tooth sensitivity caused by in-office bleaching procedures.
Study Overview
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
SE
-
Aracaju, SE, Brazil, 49060100
- Universidade Federal de Sergipe
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- At least 18 years old patients of both genders presenting good general/oral health;
- All maxillary anterior teeth presenting shade equal or darker than 2M2 at Vita bleachguide guide (Vita-Zahnfabrik, Germany);
- Signed the form accepting to participate of this study.
Exclusion Criteria:
- Presence of caries lesions, restorations and/or endodontic treatment at any maxillary anterior teeth.
- Undergone tooth-whitening procedures;
- Pregnant/lactating;
- Presence of periodontal diseases;
- Presence of severe tooth discoloration by tetracycline stains or fluorosis;
- Any kind of medicine, bruxism habits or any other pathology that can cause sensitivity (such as recession, dentin exposure);
- Continuous use of drugs with anti-inflammatory actions;
- Presence of tooth hypersensitivity at baseline measurement;
- Any known adverse effects caused by Naproxen;
- Non-attendance to any session of evaluation or bleaching.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Placebo
|
The patient will receive a single-dose of Naproxen (500 mg) one hour before the bleaching procedure.
|
Experimental: Naproxen
|
The patient will receive a single-dose of Naproxen (500 mg) one hour before the bleaching procedure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Risk to Tooth sensitivity - during procedure
Time Frame: During the bleaching procedure
|
The tooth sensitivity will be evaluated using a 5-point Verbal rating scale (VRS), where 0 = none, 1 = mild, 2 = moderate, 3 = considerable and 4 = severe.
Score different from 0 will determine presence of sensitivity.
The risk of tooth sensitivity will be determined by relative risk assessed by ratio between absolute risk of experimental condition by those observed in control.
The 95% confidence interval will be calculated.
|
During the bleaching procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Level of tooth sensitivity - during procedure
Time Frame: During the bleaching procedure
|
The tooth sensitivity will be evaluated using a 5-point Verbal rating scale (VRS), where 0 = none, 1 = mild, 2 = moderate, 3 = considerable and 4 = severe.
|
During the bleaching procedure
|
Risk of tooth sensitivity - after procedure
Time Frame: 24 hours after bleaching prcedure
|
The tooth sensitivity will be evaluated using a 5-point Verbal rating scale (VRS), where 0 = none, 1 = mild, 2 = moderate, 3 = considerable and 4 = severe.
Score different from 0 will determine presence of sensitivity.
The risk of tooth sensitivity will be determined by relative risk assessed by ratio between absolute risk of experimental condition by those observed in control.
The 95% confidence interval will be calculated.
|
24 hours after bleaching prcedure
|
Level of tooth sensitivity - after procedure
Time Frame: 24 hours after bleaching prcedure
|
The tooth sensitivity will be evaluated using a 5-point Verbal rating scale (VRS), where 0 = none, 1 = mild, 2 = moderate, 3 = considerable and 4 = severe.
|
24 hours after bleaching prcedure
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Efficacy of bleaching
Time Frame: 7 days after bleaching procedure
|
A spectrophotometer will be used to assess the color alteration, while the parameter "L", "a" and "b" will be recorded.
|
7 days after bleaching procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2015
Primary Completion (Actual)
June 1, 2016
Study Completion (Actual)
October 1, 2016
Study Registration Dates
First Submitted
May 29, 2015
First Submitted That Met QC Criteria
June 1, 2015
First Posted (Estimate)
June 4, 2015
Study Record Updates
Last Update Posted (Estimate)
October 26, 2016
Last Update Submitted That Met QC Criteria
October 24, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pain
- Neurologic Manifestations
- Stomatognathic Diseases
- Tooth Diseases
- Facial Pain
- Dentin Sensitivity
- Toothache
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Enzyme Inhibitors
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Cyclooxygenase Inhibitors
- Gout Suppressants
- Naproxen
Other Study ID Numbers
- UFSergipe
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tooth Bleaching
-
Universidade IbirapueraFundação de Amparo à Pesquisa do Estado de São PauloUnknown
-
Brighttonix Medical Ltd.Withdrawn
-
University of ChileCompleted
-
Fujian Medical UniversityCompleted
-
Sun Yat-sen UniversityCompleted
-
Cairo UniversityCompleted
-
Grupo de Investigação em Bioquímica e Biologia...Ivoclar Vivadent AGUnknownQuality of Life | Tooth BleachingPortugal
-
Sun Yat-sen UniversityShenzhen Yunding Information Technology Co., Ltd.Recruiting
-
Medipol UniversityCompleted
-
Universidade Federal do ParaNot yet recruitingTooth Bleaching | Sensitivity, ToothBrazil
Clinical Trials on Naproxen
-
Johnson & Johnson Consumer Inc., McNeil Consumer...Completed
-
BayerCompletedPain, PostoperativeUnited States
-
Giovana Maria WeckwerthFundação de Amparo à Pesquisa do Estado de São PauloCompletedPain | Impacted Third Molar Tooth | Other Surgical ProceduresBrazil
-
Johnson & Johnson Consumer Inc., McNeil Consumer...Completed
-
Johnson & Johnson Consumer Inc., McNeil Consumer...CompletedPost-operative Dental PainUnited States
-
Galeno Desenvolvimento de Pesquisas ClínicasBiolab Sanus FarmaceuticaCompleted
-
NicOxCompletedHypertension | OsteoarthritisUnited States